» Articles » PMID: 26272212

Acute Exposure to Electronic and Combustible Cigarette Aerosols: Effects in an Animal Model and in Human Alveolar Cells

Overview
Specialty Public Health
Date 2015 Aug 15
PMID 26272212
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Smoking electronic cigarettes (ECIG) is promoted as a safer alternative to smoking combustible cigarettes. This study investigates the effects of ECIG aerosol and cigarette smoke (CS) in an animal model and in human alveolar cell cultures (A549).

Methods: Mice were divided into Control, ECIG, and CS. Animals were exposed for 6h/d to either lab air, ECIG or CS, for of 3 days. Total particulate matter exposure for the ECIG was set at higher levels compared to CS. Lung injury was determined by: (1) measurement of wet-to-dry ratio; (2) albumin concentration in the bronchoalveolar lavage fluid; (3) transcriptional expression of inflammatory mediators IL-1β, IL-6, TNF-α; (4) oxidative stress; (5) assessment of cell death; and (6) lung histopathology. Human alveolar cell cultures were treated with various concentrations of ECIG and CS aerosol extracts and the effects on cell proliferation were evaluated.

Results: Wet-to-dry ratio was higher in CS when compared to ECIG. Albumin leak in bronchoalveolar lavage fluid was evident in CS but not in ECIG. ECIG exposure was only associated with a significant increase in IL-1β. In contrast, CS exposure resulted in significant increases in IL-1β, IL-6, TNF-α expression, and oxidative stress. TUNEL staining demonstrated significant cell death in CS but not in ECIG. At the cellular level, ECIG and CS extracts reduced cell proliferation, however, CS exhibited effects at lower concentrations.

Conclusion: Despite higher exposure conditions, ECIG exhibited less toxic effects on lungs of experimental animals and on A549 cell cultures when compared to CS.

Citing Articles

Acute and chronic effects of vaping electronic devices on lung physiology and inflammation.

Masso-Silva J, Byun M, Crotty Alexander L Curr Opin Physiol. 2024; 22.

PMID: 38550798 PMC: 10978006. DOI: 10.1016/j.cophys.2021.06.001.


A Practical Framework for Novel Electronic Nicotine Delivery System Evaluation: Chemical and Toxicological Characterization of JUUL2 Aerosol and Comparison with Reference Cigarettes.

Cook D, Lalonde G, Oldham M, Wang J, Bates A, Ullah S Toxics. 2024; 12(1).

PMID: 38250996 PMC: 10820849. DOI: 10.3390/toxics12010041.


Consideration of vaping products as an alternative to adult smoking: a narrative review.

Foster J Subst Abuse Treat Prev Policy. 2023; 18(1):67.

PMID: 37974269 PMC: 10655401. DOI: 10.1186/s13011-023-00571-w.


Inhalation of electronic cigarettes slightly affects lung function and inflammation in mice.

Dai Y, Duan K, Huang G, Yang X, Jiang X, Chen J Front Toxicol. 2023; 5:1232040.

PMID: 37731664 PMC: 10507352. DOI: 10.3389/ftox.2023.1232040.


The Substitution of Fifty Percent of Combustible Tobacco Smoke Exposure With Either Electronic Cigarettes or Heated tobacco Products Did Not Attenuate Acute Lung Injury in an Animal Model.

Husari A, El-Harakeh M, Shihadeh A, Zeid Daou M, Bitar H, Karaoghlanian N Nicotine Tob Res. 2023; 25(7):1361-1368.

PMID: 36943313 PMC: 10256882. DOI: 10.1093/ntr/ntad045.


References
1.
Goniewicz M, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J . Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2013; 23(2):133-9. PMC: 4154473. DOI: 10.1136/tobaccocontrol-2012-050859. View

2.
Husari A, Khayat A, Awdeh H, Hatoum H, Nasser M, Mroueh S . Activated protein C attenuates acute lung injury and apoptosis in a hyperoxic animal model. Shock. 2009; 33(5):467-72. DOI: 10.1097/SHK.0b013e3181c69213. View

3.
Lim S, Vos T, Flaxman A, Danaei G, Shibuya K, Adair-Rohani H . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380(9859):2224-60. PMC: 4156511. DOI: 10.1016/S0140-6736(12)61766-8. View

4.
Mannino D, Buist A . Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007; 370(9589):765-73. DOI: 10.1016/S0140-6736(07)61380-4. View

5.
Regan A, Promoff G, Dube S, Arrazola R . Electronic nicotine delivery systems: adult use and awareness of the 'e-cigarette' in the USA. Tob Control. 2011; 22(1):19-23. DOI: 10.1136/tobaccocontrol-2011-050044. View